Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DEVICE/DRUG APPROVALS

OBR Oncology

FDA Approves Irinotecan Liposome Combo in Metastatic Pancreatic Cancer

Hematology/Oncology February 20th 2024

OBR Oncology

Oncologists Don’t See Eye-to-Eye With Other Specialists About FDA

Hematology/Oncology February 20th 2024

Infectious Disease Special Edition (IDSE)

FDA Revises EUA for Paxlovid

Family Medicine/General Practice February 14th 2024

Psychiatry Advisor

Drug Maker Says Women Can Now Access Postpartum Depression Pill

Obstetrics & Gynecology January 23rd 2024

Practical Neurology

HyQvia Treatment for Chronic Inflammatory Demyelinating Polyneuropathy Receives FDA Approval

Neurology January 23rd 2024

Hemophilia News Today

Approved Roctavian ‘Liberating’ for 1st US Patient Treated Outside Trials

Hematology January 22nd 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form